Pancreatic Cancer Specialists Getting a Jump on Daraxonrasib
Who reported it (2)
- Intermountain Health Oncologists Say New Drug to Treat Pancreatic Cancer May Be a “Game Changer” as 10 Intermountain Hospitals Join National Initiative Intermountain Health · 29d ago
- Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer Nature · 29d ago broke it first
Momentum
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Related trends
Nine-year-old boy in serious condition after infection caused by brain-eating amoeba
A nine-year-old boy is hospitalized in serious and critical condition after contracting a rare brain-eating amoeba.
7 new dementia risk factors revealed
Seven new dementia risk factors spark fresh public‑health push as millions remain unaware.
Opinion
Measles deaths rise, sparking petitions and calls for the health secretary’s resignation.
Scientists Find 'Ominous' Signs of Artery Damage in Nearly 8 in 10 Young Adults
A new guideline urges holistic care even as a study finds almost 8 in 10 young adults show early artery damage.
Nicotine vapes best chance to quit smoking, major review finds
A new major review crowns nicotine vapes the most effective tool for quitting smoking, sparking health‑policy debate.
Two die of measles in Pennsylvania outbreak, health officials say
Two unvaccinated Pennsylvanians die of measles as schools prepare to open, marking the nation’s first measles fatalities this year